A New Era in HIV Prevention with Long-Acting Injections
Zimbabwe has started rolling out Lenacapavir, the new long-acting injectable HIV-prevention drug, becoming one of the first countries in the world to do so. Lenacapavir is the first twice-yearly injectable pre-exposure prophylaxis (PrEP) for HIV, offering a highly effective, long-acting alternative to daily oral pills. With only two doses per year, experts say it provides…